Your session is about to expire
← Back to Search
Behavioural Intervention
DASH Diet for Kidney Stones
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-reported history of kidney stone disease
Be older than 18 years old
Must not have
Nephrotic syndrome
Urinary retention requiring catheterization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days 6-7 of the assigned intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to determine the effect of following a healthy diet on the risk of kidney stones. The researchers will test the hypothesis that a DASH-style diet can improve certain factors related to kidney stone risk
Who is the study for?
This trial is for individuals with Kidney Stone Disease (KSD) who are interested in seeing if diet changes can affect their condition. Participants will be provided all meals and must follow either a DASH-style or Western-style diet strictly for one week.
What is being tested?
The study aims to compare the effects of a healthy DASH-style diet versus a typical Western-style diet on factors in the urine that contribute to kidney stones. Participants will be randomly assigned to one of these diets, which they'll eat exclusively for the duration of the trial.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include digestive adjustments such as bloating or discomfort due to new foods introduced by the diets.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had kidney stones before.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have nephrotic syndrome.
Select...
I need a catheter to help me urinate.
Select...
I have an overactive thyroid.
Select...
I have been diagnosed with primary hyperparathyroidism.
Select...
I have cystinuria.
Select...
My kidney function is reduced, with an eGFR below 60.
Select...
I have been diagnosed with renal tubular acidosis.
Select...
I am currently taking acetazolamide, topiramate, or zonisamide.
Select...
I have been diagnosed with primary hyperoxaluria.
Select...
I have been diagnosed with sarcoidosis.
Select...
I am on dialysis.
Select...
I have received a kidney transplant.
Select...
I have a condition that affects how my body absorbs nutrients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ days 6-7 of the assigned intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days 6-7 of the assigned intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Difference between the two arms in supersaturation of calcium oxalate
Secondary study objectives
Difference between the two arms in supersaturation of calcium oxalate between the baseline and intervention periods
Difference between the two arms in supersaturation of calcium phosphate
Difference between the two arms in supersaturation of uric acid
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Western-Style DietExperimental Treatment1 Intervention
For seven days, participants will consume a diet characterized by characterized by higher intake of red meat, sweets, and items containing added sugar, processed starches, and seed oils, in addition to lower intake of fruits, vegetables, and low-fat dairy.
Group II: DASH-Style DietExperimental Treatment1 Intervention
For seven days, participants will consume a diet characterized by higher intake of fruits, vegetables, and low-fat dairy, in addition to whole grains, poultry, fish, and nuts, but smaller amounts of red meat, sweets, and sugar-containing beverages.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,325 Total Patients Enrolled
13 Trials studying Kidney Stones
693 Patients Enrolled for Kidney Stones